Prot #DMVT-505-2104: Open Label Maximal Use Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Tapinarof Cream, 1% in Pediatric Subjects with Extensive Atopic Dermatitis

Project: Research project

Project Details

StatusActive
Effective start/end date12/22/2112/22/24

Funding

  • SynteractHCR, Inc. (Prot #DMVT-505-2104)
  • Dermavant Sciences, Inc. (Prot #DMVT-505-2104)